Muzikant Adam 4
4 · Flexion Therapeutics Inc · Filed Jan 7, 2021
Insider Transaction Report
Form 4
Muzikant Adam
Chief Business Officer
Transactions
- Sale
Common Stock
2021-01-05$11.13/sh−4,005$44,576→ 73,455 total
Footnotes (2)
- [F1]Sale of shares to cover tax withholding obligations associated with the vesting of restricted stock unit awards granted to the Reporting Person on February 1, 2018, March 1, 2019, and March 2, 2020.
- [F2]The weighted average sale price for the transaction reported was $11.13. The shares were sold at a range of prices between $11.11 and $11.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.